Summary
Syngene International Ltd (Syngene) a subsidiary of Biocon Ltd is a contract research organization that provides integrated services. The organization offers drug discovery and development services that include lead generation and optimization, medicinal chemistry, toxicology, custom synthesis, in vivo pharmacology, process research and development, cGMP manufacturing, formulations and clinical development services. Syngene serves various sectors such as pharmaceutical, animal health, biotechnology, agrochemicals, consumer health, cosmetic and nutrition companies. The company works in partnership with global pharmaceutical and biotechnology companies to support their clinical development programs across the US, Europe and Asia Pacific including Japan. Syngene is headquartered in Bangalore, Karnataka, India.
Syngene International Ltd (SYNGENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Syngene International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Syngene International Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Syngene May Raise Over USD50 Million in Venture Financing 10
Private Equity 11
Silver Leaf Oak Acquires 10% Stake in Syngene International from Biocon Research for USD62.2 Million 11
IVF Trustee Acquires 10% Stake in Syngene International for USD62 Million 13
GE Equity International Mauritius Completes Acquisition Of 7.69% Stake In Syngene International For US$23 Million 14
Partnerships 16
Saniona Enters into Agreement with Syngene 16
Syngene International Extends R&D Agreement with Bristol-Myers Squibb 17
Abbott India Enters Into Joint Venture Agreement With Syngene International 18
Cellectis bioresearch Enters Into Co-Development Agreement With Syngene International 19
Syngene International Expands Co-Development Agreement With Endo Pharma 20
Syngene International Enters Into An Agreement With Endo Pharma 21
Merger 22
Keats Healthcare and Clinigen Healthcare Merge with Clinigen 22
Equity Offering 23
Syngene International to Raise up to USD87 Million in IPO 23
Syngene International Ltd - Key Competitors 25
Key Employees 26
Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Tables
Syngene International Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Syngene International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Syngene International Ltd, Deals By Therapy Area, 2010 to YTD 2016 8
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Syngene May Raise Over USD50 Million in Venture Financing 10
Silver Leaf Oak Acquires 10% Stake in Syngene International from Biocon Research for USD62.2 Million 11
IVF Trustee Acquires 10% Stake in Syngene International for USD62 Million 13
GE Equity International Mauritius Completes Acquisition Of 7.69% Stake In Syngene International For US$23 Million 14
Saniona Enters into Agreement with Syngene 16
Syngene International Extends R&D Agreement with Bristol-Myers Squibb 17
Abbott India Enters Into Joint Venture Agreement With Syngene International 18
Cellectis bioresearch Enters Into Co-Development Agreement With Syngene International 19
Syngene International Expands Co-Development Agreement With Endo Pharma 20
Syngene International Enters Into An Agreement With Endo Pharma 21
Keats Healthcare and Clinigen Healthcare Merge with Clinigen 22
Syngene International to Raise up to USD87 Million in IPO 23
Syngene International Ltd, Key Competitors 25
Syngene International Ltd, Key Employees 26
Syngene International Ltd, Other Locations 27
Syngene International Ltd, Subsidiaries 27
List of Figures
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8